KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia
Hauser, Robert A, Factor, Stewart A, Marder, Stephen R, Knesevich, Mary Ann, Ramirez, Paul M, Jimenez, Roland, Burke, Joshua, Liang, Grace S, O’Brien, Christopher F
Published in The American journal of psychiatry (01.05.2017)
Published in The American journal of psychiatry (01.05.2017)
Get full text
Journal Article
The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study
Factor, Stewart A, Remington, Gary, Comella, Cynthia L, Correll, Christoph U, Burke, Joshua, Jimenez, Roland, Liang, Grace S, O'Brien, Christopher F
Published in The journal of clinical psychiatry (01.11.2017)
Published in The journal of clinical psychiatry (01.11.2017)
Get more information
Journal Article
A long-term, open-label study of valbenazine for tardive dyskinesia
Lindenmayer, Jean-Pierre, Verghese, Cherian, Marder, Stephen R., Burke, Joshua, Jimenez, Roland, Siegert, Scott, Liang, Grace S., O’Brien, Christopher F.
Published in CNS spectrums (01.08.2021)
Published in CNS spectrums (01.08.2021)
Get full text
Journal Article
Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency
Turcu, Adina F, Spencer-Segal, Joanna L, Farber, Robert H, Luo, Rosa, Grigoriadis, Dimitri E, Ramm, Carole A, Madrigal, David, Muth, Tim, O'Brien, Christopher F, Auchus, Richard J
Published in The journal of clinical endocrinology and metabolism (01.03.2016)
Published in The journal of clinical endocrinology and metabolism (01.03.2016)
Get full text
Journal Article
Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study
Correll, Christoph U, Cutler, Andrew J, Kane, John M, McEvoy, Joseph P, Liang, Grace S, O'Brien, Christopher F
Published in The journal of clinical psychiatry (18.12.2018)
Published in The journal of clinical psychiatry (18.12.2018)
Get more information
Journal Article
NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study
O'Brien, Christopher F., Jimenez, Roland, Hauser, Robert A., Factor, Stewart A., Burke, Joshua, Mandri, Daniel, Castro-Gayol, Julio C.
Published in Movement disorders (01.10.2015)
Published in Movement disorders (01.10.2015)
Get full text
Journal Article
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference
Stacy, Mark, Sajatovic, Martha, Kane, John M., Cutler, Andrew J., Liang, Grace S., O'Brien, Christopher F., Correll, Christoph U.
Published in Movement disorders (01.08.2019)
Published in Movement disorders (01.08.2019)
Get full text
Journal Article
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia
Marder, Stephen R, Singer, Carlos, Lindenmayer, Jean-Pierre, Tanner, Caroline M, Comella, Cynthia L, Verghese, Cherian, Jimenez, Roland, Liang, Grace S, Burke, Joshua, OʼBrien, Christopher F
Published in Journal of clinical psychopharmacology (01.11.2019)
Published in Journal of clinical psychopharmacology (01.11.2019)
Get more information
Journal Article
Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain
Wyrwich, Kathleen W., O’Brien, Christopher F., Soliman, Ahmed M., Chwalisz, Kristof
Published in Reproductive sciences (Thousand Oaks, Calif.) (01.11.2018)
Published in Reproductive sciences (Thousand Oaks, Calif.) (01.11.2018)
Get full text
Journal Article
Clozapine use in Parkinson's disease: a retrospective analysis of a large multicentered clinical experience
Trosch, R M, Friedman, J H, Lannon, M C, Pahwa, R, Smith, D, Seeberger, L C, O'Brien, C F, LeWitt, P A, Koller, W C
Published in Movement disorders (01.05.1998)
Published in Movement disorders (01.05.1998)
Get more information
Journal Article